Khiron Life Sciences Corp.
Rank 51
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$1.4913
USD
5.91%
Market cap
$169,903,615
Total volume
$811,328
Shares outstanding
113,927,120
Rank 51
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$576,699
|
71.08% |
$1.4913
|
| KHRNF |
Total volume
$234,629
|
28.92% |
Stock price
$1.4870
|
Chart